- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Sebelius's Claim that Insurance Premiums are 16% Lower Than CBO Projected
Estimates from the nonpartisan Congressional Budget Office are considered the gold standard in Washington.
Estimates from the nonpartisan Congressional Budget Office are considered the gold standard in Washington. The budget impact of every bill voted on by Congress is calculated by CBO analysts — and their findings often make a difference in whether legislation passes or not.
That’s why politicians often tout CBO’s estimates. So we were curious last week when Secretary Sebelius cited a CBO projection of insurance rates — and how actual premiums turned out to be lower than expected. What’s the source of this factoid?
before
HHS directed The Fact Checker to a report released in September by the HHS Assistant Secretary for Planning and Evaluation (ASPE), which stated that “premiums tax credits will be more than 16 percent lower than projected.” The report explained that “the weighted average second lowest cost silver plan for 48 states (including DC) is 16 percent below projections based on the ASPE-derived Congressional Budget Office premiums.”
Read the full story here: http://wapo.st/1e38SeK
Source: The Washington Post
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
For Neuromuscular Disease Community, an Era of Opportunities and Threats
March 17th 2025Robert Califf, MD, former commissioner of the FDA, delivered a keynote address at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference that highlighted the enormous opportunities for progress in neuromuscular disease care amid a changing policy environment.
Read More
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More
Oz Confirmation Hearing Probes Vision for Medicaid but Coalesces Around Well-Being
March 14th 2025Mehmet Oz, MD, the nominee to lead CMS under the Trump administration, testified in a confirmation hearing before the Senate Finance Committee, where he found common ground on improving outcomes through healthier lifestyle choices but encountered repeated questions on potential Medicaid cuts.
Read More
